Study of DA-9801 to Treat Diabetic Neuropathy

NCT01822925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy

Interventions

DRUG: DA-9801 300mg
DRUG: DA-9801 600mg
DRUG: DA-9801 900mg
DRUG: Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.

Collaborators

[object Object]